Authors conclude that CLDN7 is expressed in the rapidly proliferating and dominant cell population of pancreatic cancer tissues and represents a potential molecular target for pancreatic cancer treatment (17). This evidence concerns the gene CLDN7 and familial pancreatic carcinoma.